John M Canty Jr
Overview
Explore the profile of John M Canty Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1769
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mylonas N, Siokatas G, Zacharia E, Pol C, Rolland T, Kyriazis I, et al.
Cardiovasc Res
. 2025 Mar;
PMID: 40079359
Aims: Activation of the transcriptional factor Krüppel-like factor 5 (KLF5) is detrimental to chronic heart failure. We explored the involvement of KLF5 in myocardial ischemia/reperfusion injury. Methods And Results: Yorkshire...
2.
Neelamegham S, Canty Jr J
JACC Basic Transl Sci
. 2024 Mar;
9(2):200-202.
PMID: 38510720
No abstract available.
3.
Sherpa M, Sonkawade S, Jonnala V, Pokharel S, Khazaeli M, Yatsynovich Y, et al.
Cells
. 2023 May;
12(9).
PMID: 37174619
Background: Myocardial fibrosis is a common postmortem finding among individuals with Sudden Cardiac Death (SCD). Numerous in vivo and in vitro studies have shown that increased galectin-3 (gal3) expression into...
4.
Techiryan G, Weil B, Young R, Canty Jr J
Am J Physiol Heart Circ Physiol
. 2022 Sep;
323(5):H904-H916.
PMID: 36083793
Allogeneic cardiosphere-derived cell (CDC) therapy has been demonstrated to improve myocardial function when administered to reperfused myocardial infarcts. We previously pretreated animals with low-dose cyclosporine immunosuppression to limit allogeneic CDC...
5.
Malhotra S, Singh V, Fallavollita J, Canty Jr J
JACC Cardiovasc Imaging
. 2022 Jun;
15(6):1164-1166.
PMID: 35680225
No abstract available.
6.
Canty Jr J
Am J Physiol Heart Circ Physiol
. 2022 May;
323(1):H1-H15.
PMID: 35559722
Troponin released from irreversibly injured myocytes is the gold standard biomarker for the rapid identification of an acute coronary syndrome. In acute myocardial infarction, necrotic cell death is characterized by...
7.
8.
Wang J, Zelt J, Kaps N, Lavallee A, Renaud J, Rotstein B, et al.
J Nucl Cardiol
. 2021 Aug;
28(5):2419-2420.
PMID: 34448095
No abstract available.
9.
Momeni A, Eagler L, Lo C, Weil B, Canty Jr J, Lang J, et al.
Biomaterials
. 2021 Aug;
276:121048.
PMID: 34343858
The efficacy of cell-based therapies relies on targeted payload delivery and enhanced cell retention. In vitro and in vivo studies suggest that the glycoengineering of mesenchymal and cardiosphere-derived cells (CDCs)...
10.
Wang J, Zelt J, Kaps N, Lavallee A, Renaud J, Rotstein B, et al.
J Nucl Cardiol
. 2021 Aug;
29(2):413-425.
PMID: 34341953
Background: In ischemic cardiomyopathy patients, cardiac sympathetic nervous system dysfunction is a predictor of sudden cardiac arrest (SCA). This study compared abnormal innervation and perfusion measured by [C]meta-hydroxyephedrine (HED) vs...